This installment of the PATH Malaria Learning Series highlights the PATH Market Dynamics program’s contribution to PATH’s work in the fight against malaria, providing an overview of our market access approach and highlighting three case studies. These case studies share PATH's experiences in ensuring access and availability of tools for malaria burden reduction and elimination such as G6PD testing, chloroquine, and artemisinin.

The goal of the Malaria Learning Series is to provide concise briefings on the latest evidence in malaria science and learnings from across the PATH portfolio.